The impact of co-morbidity on the quality of life of people with dementia: findings from the IDEAL study - PubMed (original) (raw)

. 2019 May 1;48(3):361-367.

doi: 10.1093/ageing/afy155.

Yu-Tzu Wu 1 2, Fiona E Matthews 3, Anthony Martyr 1, Catherine Quinn 1, Isla Rippon 4, Jennifer Rusted 5, Jeanette M Thom 6, Michael D Kopelman 7, John V Hindle 1, Roy W Jones 8, Linda Clare 1 9

Affiliations

The impact of co-morbidity on the quality of life of people with dementia: findings from the IDEAL study

Sharon M Nelis et al. Age Ageing. 2019.

Abstract

Background: The aim was to investigate the co-morbidity profile of people with dementia and examine the associations between severity of co-morbidity, health-related quality of life (HRQoL) and quality of life (QoL).

Methods: The improving the experience of Dementia and Enhancing Active Life (IDEAL) cohort consisted of 1,547 people diagnosed with dementia who provided information on the number and type of co-morbid conditions. Participants also provided ratings of their health-related and dementia-specific QoL.

Results: The majority of the sample were living with more than one chronic condition. Hypertension was commonly reported and frequently combined with connective tissue disease, diabetes and depression. The number of co-morbid conditions was associated with low QoL scores, and those with severe co-morbidity (≥5 conditions) showed the greatest impact on their well-being.

Conclusions: Co-morbidity is an important risk factor for poor QoL and health status in people with dementia. Greater recognition of the nature and impact of co-morbidity is needed to inform support and interventions for people with dementia and a multidisciplinary approach to care provision is recommended.

Keywords: Alzheimer’s; depression; multimorbidities; older people.

© The Author(s) 2018 Published by Oxford University Press on behalf of the British Geriatrics Society.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Prevalence of co-morbid conditions associated with dementia

Comment in

Similar articles

Cited by

References

    1. Yancik R, Ershler W, Satariano W, Hazzard W, Cohen HJ, Ferrucci L. Report of the National Institute on Aging Task Force on Comorbidity. J Gerontol A Biol Sci Med Sci 2007; 62: 275–80. - PMC - PubMed
    1. Melzer D, Delgado J, Winder R, Masoli J, Richards S, Ble A. The Age UK Almanac of Disease Profiles in Later Life. UK: Ageing Research Group, University of Exeter, 2015.
    1. Poblador-Plou B, Calderón-Larrañaga A, Marta-Moreno J et al. . Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry 2014; 14: 84. - PMC - PubMed
    1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37–43. - PubMed
    1. Meyers BS. Depression and dementia: comorbidities, identification, and treatment. J Geriatr Psychiatry Neurol 1998; 11: 201–5. - PubMed

Publication types

MeSH terms

LinkOut - more resources